Global Benefit of SGLT2 Inhibitors in Heart Failure With Reduced Ejection Fraction

By sjmartinez • April 30, 2023

Brownell NK, Ziaeian B, Fonarow GC. Global Benefit of SGLT2 Inhibitors in Heart Failure With Reduced Ejection Fraction. JACC Asia. 2022 Apr 19;2(2):154-156. doi: 10.1016/j.jacasi.2022.03.002. PMID: 36339123; PMCID: PMC9627794.

Tags: Asia, Cardiology/Epi, ejection fraction, heart failure, Publications, SGLT2 inhibitor

Treated HIV infection is not associated with carotid vascular inflammation or plaque progression as assessed by dynamic contrast magnetic resonance imaging

Shakil S, Chen D, Isquith D, Sapp J, Pommier I, Chu B, Guo Y, Canton G, Balu N, Yuan C, Hatsukami T, Maynard C, Zhao[...]

Differences in Ambulatory Care Outcomes Between Trainees and Faculty: A Multi-center Study

Graham KL, Amat M, Norian E, Li J, Weintraub J, Shaik A, Boggan JC, Davy J, Lyons A, Semour L, Rogers R, Davis RB. Differences[...]

Comparative assessment of CAC and SIS plaque burden categories via AI-guided quantitative CT analysis

Iskander B, Ichikawa K, Punnanithinont N, Kambalapalli S, Kinninger A, Krishnan S, Lakshmanan S, Roy S, Budoff MJ. Comparative assessment of CAC and SIS plaque[...]